Results 121 to 130 of about 1,427 (143)

ATG9A vesicles are a subtype of intracellular nanovesicle.

open access: yesJ Cell Sci
Fesenko M   +4 more
europepmc   +1 more source

Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation. [PDF]

open access: yesInt J Mol Sci
Muntiu A   +12 more
europepmc   +1 more source

High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor. [PDF]

open access: yesNeuro Oncol
Delaidelli A   +20 more
europepmc   +1 more source

ATG9 vesicles are a subtype of intracellular nanovesicle

open access: yes
Fesenko M   +4 more
europepmc   +1 more source

AML poor prognosis factor, TPD52, is associated with the maintenance of haematopoietic stem cells through regulation of cell proliferation

open access: yesJournal of Cellular Biochemistry, 2021
Acute myeloid leukaemia (AML) is a blood cancer where undifferentiated myeloid cells are increased in the bone marrow and peripheral blood. As AML is dangerous and shows poor prognosis, many researchers categorised the relevant cytogenetic factors ...
Yoonsung Lee   +2 more
exaly   +2 more sources

Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer [PDF]

open access: yesFEBS Letters, 2014
Our recent study of the microRNA expression signature of prostate cancer (PCa) revealed that microRNA-224 (miR-224) is significantly downregulated in PCa tissues.
Hideki Enokida   +2 more
exaly   +2 more sources

Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells

open access: yesTumor Biology, 2016
The tumour protein D52 isoform 1 (PC-1), a member of the tumour protein D52 (TPD52) protein family, is androgen-regulated and prostate-specific expressed.
Simone Venz   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy